2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum

C64H64N3OPt- — CID 153477957

IUPAC2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum
SMILES[2H]C([2H])([2H])c1cc(-c2c(C([2H])(C)C)cccc2C([2H])(C)C)ccc1-n1c(-c2cc(C(C)(C)C)cc(C(C)(C)C)c2O)nc2c(-c3[c-]c(-c4cc(-c5ccc(C)cc5)ccn4)cc(-c4ccccc4)c3)cccc21.[Pt]
InChIInChI=1S/C64H64N3O.Pt/c1-39(2)51-20-16-21-52(40(3)4)59(51)46-28-29-57(42(6)32-46)67-58-23-17-22-53(60(58)66-62(67)54-37-50(63(7,8)9)38-55(61(54)68)64(10,11)12)48-33-47(43-18-14-13-15-19-43)34-49(35-48)56-36-45(30-31-65-56)44-26-24-41(5)25-27-44;/h13-34,36-40,68H,1-12H3;/q-1;/i6D3,39D,40D;
InChIKeyCVRYVDXZWLNUJJ-SGNLOXDXSA-N
MW1091.34 g/mol
LogP17.38
Rot. Bonds10

About 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum

2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum (PubChem CID 153477957) has the molecular formula C64H64N3OPt- and a molecular weight of 1091.34 g/mol. Its IUPAC name is 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum.

Molecular Properties

Compound Name2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum
PubChem CID153477957
Molecular FormulaC64H64N3OPt-
Molecular Weight1091.34 g/mol
Exact Mass1090.50
IUPAC Name2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum
SMILES[2H]C([2H])([2H])c1cc(-c2c(C([2H])(C)C)cccc2C([2H])(C)C)ccc1-n1c(-c2cc(C(C)(C)C)cc(C(C)(C)C)c2O)nc2c(-c3[c-]c(-c4cc(-c5ccc(C)cc5)ccn4)cc(-c4ccccc4)c3)cccc21.[Pt]
InChIInChI=1S/C64H64N3O.Pt/c1-39(2)51-20-16-21-52(40(3)4)59(51)46-28-29-57(42(6)32-46)67-58-23-17-22-53(60(58)66-62(67)54-37-50(63(7,8)9)38-55(61(54)68)64(10,11)12)48-33-47(43-18-14-13-15-19-43)34-49(35-48)56-36-45(30-31-65-56)44-26-24-41(5)25-27-44;/h13-34,36-40,68H,1-12H3;/q-1;/i6D3,39D,40D;
InChIKeyCVRYVDXZWLNUJJ-SGNLOXDXSA-N
XLogP17.38
TPSA50.94 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds10
Heavy Atoms69
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001091.34
LogP ≤ 517.38
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum?
The IUPAC name of 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum (CID 153477957) is 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum.
What is the SMILES notation for 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum?
The canonical SMILES for 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum is [2H]C([2H])([2H])c1cc(-c2c(C([2H])(C)C)cccc2C([2H])(C)C)ccc1-n1c(-c2cc(C(C)(C)C)cc(C(C)(C)C)c2O)nc2c(-c3[c-]c(-c4cc(-c5ccc(C)cc5)ccn4)cc(-c4ccccc4)c3)cccc21.[Pt].
What is the InChIKey of 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum?
The InChIKey is CVRYVDXZWLNUJJ-SGNLOXDXSA-N. The full InChI is InChI=1S/C64H64N3O.Pt/c1-39(2)51-20-16-21-52(40(3)4)59(51)46-28-29-57(42(6)32-46)67-58-23-17-22-53(60(58)66-62(67)54-37-50(63(7,8)9)38-55(61(54)68)64(10,11)12)48-33-47(43-18-14-13-15-19-43)34-49(35-48)56-36-45(30-31-65-56)44-26-24-41(5)25-27-44;/h13-34,36-40,68H,1-12H3;/q-1;/i6D3,39D,40D;.
What are the key properties of 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum?
2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum has a molecular weight of 1091.34 g/mol, XLogP of 17.38, 10 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[1-[4-[2,6-bis(2-deuteriopropan-2-yl)phenyl]-2-(trideuteriomethyl)phenyl]-4-[3-[4-(4-methylphenyl)-2-pyridinyl]-5-phenylbenzene-2-id-1-yl]benzimidazol-2-yl]-4,6-ditert-butylphenol;platinum is sourced from PubChem (CID 153477957), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).